MedCAC Calls For More Evidence On Radiation Therapy For Prostate Cancer

CMS is unlikely to consider national coverage of radiation therapy for prostate cancer anytime soon because of insufficient evidence on the effectiveness of the treatment, according to Marcel Salive, director of medical and surgical services in CMS' Coverage and Analysis Group